More recently, studies have demonstrated the influence of the structure of individual bile acids on bile flow as their pattern of conjugation, critical micellar concentration, and relative hydrophilicity influence bile flow and biliary lipid secretion (5) (6) (7) (8) (9) .
The classical definition of Tm implies that a constant Tm rate is maintained in the face of increasing delivery of the substance above its Tm. These conditions cannot be satisfied with bile acids except for sulfates (10) because biliary bile acid secretion rate reaches a plateau and then declines with bile flow as the infusion rate of bile acids increases (1 1-13) . In view of this limitation, Hardison coined the term bile acid SRm when the plateau is reached (12) . The SRm is an important concept as it reflects the overall rate-limiting step in the transport of bile acids through the hepatocyte (1 2, 14-19). Although some authors have shown that conjugation increases the SRm in the rat (IS), no one has yet examined the SRm in a species that like man conjugates its bile acids mainly with glycine.
Taurine fits the definition of a conditionally essential amino acid, because needs cannot be met when dietary intake is inadequate or when losses are excessive (20) . Taurine has an effect on osmoregulation (21) , on the brain and retina (22, 23) , and probably on growth (24) . However, conjugation with bile acids is its only metabolic reaction. The reported effects of this conjugation on biliary physiology are to increase bile flow (25) and bile acid pool through an increased synthesis (26) , to decrease the cholestatic potential of monohydroxylated bile acids (25) and to improve fat absorption in patients with cystic fibrosis who have an abnormally high ratio of glycine over taurine conjugated bile acids (27) .
The aim of our study was to determine if taurine could alter the SRm of CDC, the predominant bile acid of the guinea pig, and to ascertain whether this effect is dependent on a change in its conjugation pattern.
MATERIALS AND METHODS

Animals.
Male guinea pigs aged 14 to 28 days and weighing 235-320 g were obtained from Charles River Inc. (La Prairie, Qukbec, Canada), housed in a temperature-controlled room (22" C) with alternative 12 h light-dark cycles for at least 1 wk before use and fed guinea pig food ad libitum with free access to water.
Chemicals. The bile acids used in this study, CDC, GCDC, and TCDC were purchased as the sodium salts from Calbiochem (La Jolla, CA) a i d no contaminants were detected by thin layer anesthetized with 44 mg/kg ketamine hydrochloride (Ketalar, Parke Davis, Detroit, MI) and 2 mg acepromazine maleate (Atravet, Ayerst, Montreal, Qukbec, Canada). A central catheter was then positioned in the superior vena cava after its introduction in the right external jugular vein. After laparotomy, a large polyethylene tubing (PE 50, Clay Adams, Parsippany, NJ) was introduced into the common bile duct and the gallbladder was ligated. Body temperature was maintained at 39.5 f 1.0" C by a temperature-controlled heating lamp with rectal probe.
In the first phase of the study, the endogenous bile acid pool was drained for 1 h in guinea pigs maintained on a normal diet. Estimation of the SRm of CDC and of its GCDC and TCDC conjugates was then carried out by infusing in stepwise increasing rates these bile acids dissolved in a 0.45% NaCl solution containing 7.5% albumin. Each infusion rate was continued for 30 min and hepatic bile was collected continuously in 10-min aliquots. CDC was infused at rates of 0.4, 0.6, 0.8, 1.0, and 1.2 pmoll min/100 g body weight whereas the conjugates were infused at rates of 1 .O, 1.2, 1.6, 2.0, 2.4. The second part of the study involved guinea pigs with and without supplemental taurine. They were infused with CDC at a rate of 0.8, with GCDC at 1.6 and TCDC at 2.0 mol/min/100 g body weight as these rates of infusion were those leading to the SRm established in the initial phase of the study. Neither hemoglobinuria nor evidence of hemolysis on blood smears was noted in response to these doses of bile acids. At the termination of the experiments the animals were killed and the rapidly removed livers did not reveal any histological changes.
To verify that the rate-limiting step for the secretion of bile acids was at the level of the bile canalicular membrane and not at that of the hepatic uptake, a set of experiments was conducted using labeled CDC after which the distribution of radioactivity was quantitated. CDC with 14C-CDC-labeled was infused at a rate of 0.8 pmo1/100 g body weightlmin in animals with or without a supplement of taurine. Thirty-min hepatic bile collections were obtained and on termination of the experiments blood was obtained from the vena cava and urine from the bladder before removing and weighing the livers.
Analyses. Bile flow was determined gravimetrically and total bile acids were measured enzymatically (28) . The pattern of biliary bile acids was measured from 0.5 ml of bile by gas-liquid chromatography. Free, glycoconjugated, and tauroconjugated bile acids were separated on thin-layer chromatography developed in a water/n-propanol/diethylether/isoamylacetate/propionic acid (10:20:23:40:10 vol/vol) solution. The three silica bands corresponding to standards were scraped off and bile acids were extracted twice in acetic acid methanol (1: 100) containing nordeoxycholic acid as internal standard. After alkaline hydrolysis of the glycoconjugated and tauroconjugated bile acids, the media were acidified and free bile acids were extracted twice with ethylacetate. Solvolysis was camed out on a measured aliquot of the ethylacetate extractant (29) . Each of the six extracted bile fractions were then methylated and acetylated (30) . Total and individual bile acids were quantified with a Hewlett Packard 5880 gas chromatograph using a 6 feet column packed with 2% QF, on chromosorb W(HP) 100:120 mesh. Counting of 14C-CDC was carried out in 100 p1 of bile, whole blood, urine, and liver homogenate using Beckman Ready Solvent MP as scintillant, hydrogen peroxyde to reduce the quenching, and a Beckman LS 7500 liquid scintillation system (Beckman Instruments Inc., Palo Alto, CA).
Statistics. The means and SEM were calculated. The homogeneity of variance was checked by the Bartlett test (3 1). Student's t test for parallel groups or repeated data were used when appropriate. An a <0.05 was estimated as statistically significant.
RESULTS
BASR increased to a maximum of 147 + 6 nmol/min/g liver in response to the infusion of CDC at a rate of 0.8 pmol/min/ 100 g body weight: thereafter, it decreased progressively. The BASR reached a plateau of 327 f 24 nmol/min g liver for GCDC infused at a rate of 1.6 pmol/min/lOO g body weight and of 426 f 21 in response to an infusion rate of 2.0 for TCDC (Fig. 1) . The changes in bile flow observed during the infusion of bile acids were correlated with the changes in bile acid secretion in that the SRm and maximum bile flows were achieved at the same rate of infusion for the three bile acids (Fig. 1) .
Results of the experiments camed out to test the effect of supplemental taurine on the bile flow and the BASR in response to CDC at an infusion rate of 0.8 pmol/min/100 g body weight showed that taurine had no effect on bile flow but it increased (p < 0.01) the BASR from 129.7 + 3.3 nmol/min/g liver to 222.6 + 20.1 (Fig. 2) . The profile of bile acids recovered from these animals indicates that taurine led to an increase in tauroconjugates and to close to a 5-fold decrease in the ratio (6.4 + 1.0 + 1.4 f 0.3) of glyco over tauroconjugates (Fig. 3) . The (A) and bile acid secretion rate (B) during infusion of CDC and of its glycine (GCDC) and taurine (TCDC) conjugates administered in step-wise increasing rates to three groups of five guinea pigs. A decrease in bile flow was observed at a lower rate of infusion for the free bile acid than for its two conjugates. Values are expressed as mean rt SE. The BASR maximum for CDC was reached at a perfusion rate of 0.8 pmol/min/100 g body weight. The corresponding SRm was 1.6 and 2.0 pmol/min/100 g body weight for GCDC and TCDC, respectively. percent of free biliary bile acids and the extent of sulfation were not modified by taurine (Fig. 4) .
The effects of supplemental taurine on bile flow and BASR in response to the infusion of CDC-conjugates was similar to those observed with CDC in that bile flow was essentially unchanged while BASR was increased. Taurine increased ( p < 0.01) the BASR from 327 f 23 to 424 + 35 nmol/min/g liver for an infusion rate of 1.6 pmol/min/100 g body weight of GCDC and from 426 f 21 to 5 19 f 27 for an infusion rate of 2.0 pmol,? min/ 100 g body weight of TCDC. Table 1 presents the data in animals with and without taurine infused with 14C-CDC at a rate of 0.8 pmol/min/100 g body weight. The uercent of recovered labeled CDC averaged 85% on andvoff tauXne and the percent of distribution of radioactivity in bile, liver, blood, and urine was similar in the two groups.
DISCUSSION
This study determined the SRm of CDC and of its glycine and taurine conjugates in guinea pigs and explored the effect of a supplement of taurine on the BASR at the SRm for these three bile acids.
The data showing that the SRm of CDC was 2-fold lower than that of its conjugates confirms previous studies in rats (12, 16, 18, 19, 32) . The difference between the SRm of CDC and of its conjugates may be due to the change in their hydrophilic-hydrophobic balance (33) . It is known that the most hydrophilic bile salts have high hepatic secretory maxima, are not cholestatic, have a low hemolytic and detergent potential (9, 10, 35) , and exhibit little cytotoxicity in animals (12, 32, 36) and in humans (37) . There is an exception to this rule in that ursodeoxycholic acid has a very low SRm and yet has a very mild hepatotoxic potential (18) . It is of interest to note that TCDC had an SRm that was 30% higher than that of GCDC. A tendency to a larger BASR was previously noted for tauroconjugates in the guinea uig (38) but this was not documented in hamsters (5). Further-. -\ more, both studies were carried out at low perfusion rates (0.4 pmol/min/ 100 g body weight).
A daily amount of 200 to 300 mg of taurine fed to guinea pigs which normally conjugate 75% of their bile acids with glycine is reported to lead to a predominance of taurine over glycine conjugates (39) . In our study with taurine there was essentially an equal proportion of glyco and tauroconjugates and the BASR increased by 70% in response to infusion rates of CDC at the SRm. Conjugation is known to be a mechanism of detoxification of bile acids not only for free (40) but also for sulfated bile acids (25) . However, the pattern of conjugation may also be important inasmuch as the cholestatic potential of sulfated lithocholate persists when it is conjugated with glycine but not with taurine (25) . Examination of the profile of bile acids recovered in the animals pretreated with taurine and infused with CDC revealed a 3-fold increase in tauroconjugates in the absence of a significant change in either free or sulfated bile acids. The percent of free bile acids amounted to more than 10% during the CDC infusion * Intravenous CDC at a rate of 0.8 pmol/min/100 g body weight.
in control animals and increased to 17% in those with supplemental taurine. This indicates that the availability of large amounts of taurine did not decrease the percent of free bile acids despite the fact that the single transferase conjugation enzyme has a greater affinity for taurine than for glycine (41) . Although the extent of sulfation increases with cholestasis (42), bile salt TAURINE AND BILE ACID MAXIMUM SECRETORY RATE 3 7 sulfotransferase activity has not been found to be inducible (43) . Our results tend to support these findings because less than 1.5% of hepatic biliary bile acids were sulfated in response to CDC administered to animals on and off taurine. It is therefore apparent that the increased bile flow and SRm in response to taurine cannot be accounted by the synthesis of sulfated forms which are more osmotically active and which are known to increase bile flow (44) .
The data with labeled CDC show no difference between the distribution of radioactive CDC infused with or without taurine in liver, blood, and bile. This suggests that the sinusoidal uptake and the translocation across the hepatocyte were unlikely limiting steps and that the SRm of CDC was modulated by its transfer across the bile canalicular membrane. These results are in accordance with previous data showing that the maximum capacity for uptake far exceeds the maximum secretory rate (14, 15) .
The results obtained on the effect of taurine in response to CDC suggests that taurine conjugation accounts for the increased BASR especially since the BASR of TCDC at 0.8 pmol/min/100 g body weight (Fig. 1 B) corresponds to that achieved in animals with CDC and taurine (Fig. 2) . However, taurine conjugation cannot account for the fact that pretreatment with taurine augmented the BASR of both infused GCDC and TCDC. A recent study suggests that taurine feeding not only leads to increased activity of cholesterol 7-a-hydroxylase but also of HMG CoA reductase activity and results in an increase in BASR (26) . A further observation is that taurine favors enhanced low-density lipoprotein receptor binding, internalization, and degradation thereby delivering more cholesterol for bile acid synthesis and secretion (45) . It is, therefore, clear that taurine not only increases the availability of cholesterol but also the synthesis of both cholesterol and bile acids. However, the role of taurine on bile acid uptake, their transcellular transport and secretion through the bile canalicular membrane deserves further exploration.
Our observations show that free CDC had a two-fold lower SRm than glycine and taurine conjugates in the guinea pig and that, in response to taurine, there was an increase in the BASR not only of the free bile acid but also of its two conjugates. We can hypothesize that taurine modulates the SRm of bile acids by facilitation of bile canalicular excretion that may, only in part, be accounted by a change in the conjugation pattern.
